House Hearing, 110th Congress - ALLEGATIONS OF WASTE, FRAUD, AND ABUSE IN PHARMACEUTICAL PRICING: FINANCIAL IMPACTS ON FEDERAL HEALTH PROGRAMS AND THE FEDERAL TAXPAYER
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
House of Representatives, Congress."
House Hearing, 110th Congress
- ALLEGATIONS OF WASTE, FRAUD, AND ABUSE IN PHARMACEUTICAL PRICING: FINANCIAL IMPACTS ON FEDERAL HEALTH PROGRAMS AND THE FEDERAL TAXPAYER. Government. U.S. Government Printing Office https://www.govinfo.gov/app/details/CHRG-110hhrg35340.
APA
House of Representatives, Congress. (2007, February 9). House Hearing, 110th Congress - ALLEGATIONS OF WASTE, FRAUD, AND ABUSE IN PHARMACEUTICAL PRICING: FINANCIAL IMPACTS ON FEDERAL HEALTH PROGRAMS AND THE FEDERAL TAXPAYER. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/CHRG-110hhrg35340
MLA
House of Representatives, Congress. House Hearing, 110th Congress - ALLEGATIONS OF WASTE, FRAUD, AND ABUSE IN PHARMACEUTICAL PRICING: FINANCIAL IMPACTS ON FEDERAL HEALTH PROGRAMS AND THE FEDERAL TAXPAYER. U.S. Government Printing Office, (9 Feb 2007), https://www.govinfo.gov/app/details/CHRG-110hhrg35340
Bluebook
House of Representatives, Congress, ALLEGATIONS OF WASTE, FRAUD, AND ABUSE IN PHARMACEUTICAL PRICING: FINANCIAL IMPACTS ON FEDERAL HEALTH PROGRAMS AND THE FEDERAL TAXPAYER, GovInfo, (February 9, 2007), https://www.govinfo.gov/app/details/CHRG-110hhrg35340
